GDP | MHRA

Total Records 2071 to 2080 of 2802

GDP Search Results
Certificate Number	Site Details	Country	Inspection Date
UK WDA(H) 46077 Insp GDP 46077/17055049-0001	ESSEX CHEM UK LIMITED, 79 COLLEGE ROAD, HARROW, HA1 1BD, UNITED KINGDOM	UNITED KINGDOM	23/08/2017
UK WDA(H) 13556 Insp GDP 13556/90580-0004	CENTRAL PHARMACY STORES, PHARMACY DEPARTMENT, CLATTERBRIDGE HOSPITAL, CLATTERBRIDGE ROAD, WIRRAL, CH63 4JY, UNITED KINGDOM	UNITED KINGDOM	22/08/2017
UK WDA(H) 44434 Insp GDP 44434/13172685-0002	CARE UK SERVICES LIMITED, HMP HOLLESLEY BAY, PHARMACY DEPARTMENT, RECTORY ROAD, HOLLESLEY, WOODBRIDGE, IP12 3JW, UNITED KINGDOM	UNITED KINGDOM	22/08/2017
UK WDA(H) 48200 Insp GDP 48200/17196868-0001	LADYBARN LANE CHEMIST, 3 LADYBARN LANE, MANCHESTER, M14 6NQ, UNITED KINGDOM	UNITED KINGDOM	21/08/2017
UK WDA(H) 15108 Insp GDP 16827/8563-0010	MEDICAL SERVICES INTERNATIONAL LIMITED, CROMWELL HOSPITAL, CROMWELL ROAD, LONDON, SW5 0TU, UNITED KINGDOM	UNITED KINGDOM	17/08/2017
UK WDA(H) 41160 Insp GDP 41160/6088544-0003	MACPHARM LIMITED, 233 ST. CLAIR STREET, KIRKCALDY, KY1 2BY, UNITED KINGDOM	UNITED KINGDOM	16/08/2017
UK WDA(H) 21266 Insp GMP/GDP/IMP 21266/88982-0007	CHRISTIE MEDICAL PHYSICS AND ENGINEERING, NORTH WESTERN MEDICAL PHYSICS, CHRISTIE HOSPITAL NHS FOUNDATION TRUST, WILMSLOW ROAD, WITHINGTON, MANCHESTER, M20 4BX, UNITED KINGDOM	UNITED KINGDOM	16/08/2017
UK WDA(H) 44361 Insp GDP 44361/16915972-0001	DULWICH PHARMACIES LIMITED, 75 HERNE HILL, LONDON, SE24 9NE, UNITED KINGDOM	UNITED KINGDOM	15/08/2017

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX